FC
WST icon

Forte Capital’s West Pharmaceutical WST Stock Holding History

Forte Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-977
Closed -$320K – 243
2024
Q4 		$320K Sell
977
-914
-48% -$288K 0.04% 198
2024
Q3 		$568K Sell
1,891
-12,487
-87% -$3.82M 0.06% 159
2024
Q2 		$4.74M Buy
14,378
+362
+3% +$128K 0.57% 42
2024
Q1 		$5.55M Buy
14,016
+450
+3% +$166K 0.69% 41
2023
Q4 		$4.78M Sell
13,566
-133
-1% -$47.1K 0.65% 39
2023
Q3 		$5.14M Buy
13,699
+620
+5% +$240K 0.79% 32
2023
Q2 		$5M Buy
13,079
+2,475
+23% +$884K 0.72% 38
2023
Q1 		$3.67M Buy
10,604
+1,346
+15% +$393K 0.56% 43
2022
Q4 		$2.18M Sell
9,258
-5,850
-39% -$1.39M 0.37% 57
2022
Q3 		$3.72M Buy
15,108
+3,377
+29% +$1.03M 0.67% 40
2022
Q2 		$3.55M Buy
11,731
+6,733
+135% +$2.19M 0.62% 42
2022
Q1 		$2.34M Hold
4,998
– – 0.3% 59
2021
Q4 		$2.34M Buy
+4,998
New +$2.15M 0.3% 59

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Forte Capital's WST Position: Q1 2025 in Review

Forte Capital sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 977 shares — an estimated $320K sold.

Forte Capital first reported a position in WST in Q4 2021 and held it in 13 quarters. The position peaked at $5.55M in Q1 2024. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Forte Capital reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Forte Capital sold 977 West Pharmaceutical shares in Q1 2025, an estimated $320K.
  • Forte Capital first reported a position in West Pharmaceutical in Q4 2021 and held it in 13 quarters.
  • Forte Capital's West Pharmaceutical position peaked at $5.55M in Q1 2024.
  • 715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Forte Capital's 13F filing for Q1 2025, filed 2 May 2025.